Table 3.

T cells used in this study.

	PD-1		CD28		ICOS		PKCθ
	endo	exo	endo	exo	endo	exo	endo	exo
DO11.10	+	–	+	–	–	–	–*	–	Figures 1, 2, 5
DO11.10-CD28KO	+	–	KO	–	–	–	–	–	Figure 2
DO11.10-ICOS	+	–	+	–	–	+	–	–	Figure 5
DO11.10-PKCθ/ICOS	+	–	+	–	–	+	–	+	Figures 5, 6
2B4.11	+	–	+	–	–	–	–†	–	Figure 4
primary CD4+	–	–	+	–	–	–	+	–	Figures 3, 5, 6
primary CD8+	–	–	+	–	–	–	+	–	Figures 3, 5, 6
primary pre-activated CD4+	+	–	+	–	+	–	+	–	Figures 3, 4, 6, 7
primary pre-activated CD8+	+	–	+	–	+	–	+	–	Figures 3, 4, 6, 7

About

^*1/810 and

^†1/27 of primary CD4⁺ T cells by qPCR.